Variable | Value | TB treatment outcome | Total | OR | 95 % CI | P value | |
---|---|---|---|---|---|---|---|
No success | Success | ||||||
Age | 15–24 | 9 (6.0 %) | 142 (94.0 %) | 151 | 0.243 | 0.079–0.747 | 0.014 |
25–34 | 15 (8.2 %) | 169 (91.8 %) | 184 | 0.34 | 0.120–0.965 | 0.043 | |
35–49 | 10 (6.6 %) | 141 (93.4 %) | 151 | 0.272 | 0.090–0.820 | 0.021 | |
50–64 | 9 (15 %) | 51 (85 %) | 60 | 0.676 | 0.215–2.124 | 0.503 | |
65–90 | 6 (20.7 %) | 23 (79.3 %) | 29 | ||||
Gender | F | 22 (8.3 %) | 242 (91.7 %) | 264 | 0.956 | 0.531–1.722 | 0.881 |
M | 27 (8.7 %) | 284 (91.3 %) | 311 | ||||
TB classification | EP | 17 (6.7 %) | 236 (93.3 %) | 253 | 0.436 | 0.22–0.863 | 0.017 |
P/neg | 12 (6.7 %) | 168 (93.3 %) | 180 | 0.432 | 0.204–0.917 | 0.029 | |
P/pos | 20 (14.2 %) | 121 (85.8 %) | 141 | ||||
Enrollment in HIV care | No | 3 (20.0 %) | 12 (80.0 %) | 15 | 2.015 | 0.516–7.864 | 0.313 |
Yes | 17 (11.0 %) | 137 (89 %) | 154 | ||||
Co-trimoxazole given | No | 7 (17.9 %) | 32 (82.1 %) | 39 | 1.969 | 0.725–5.344 | 0.184 |
Yes | 13 (10.0 %) | 117 (90.0 %) | 130 | ||||
ART started | No | 8 (15.4 %) | 44 (84.6 %) | 52 | 1.591 | 0.608–4.161 | 0.344 |
Yes | 12 (10.3 %) | 105 (89.7 %) | 117 | ||||
HIV status | Negative | 23 (6.4 %) | 337 (93.6 %) | 360 | 0.508 | 0.271–0.954 | 0.035 |
Positive | 20 (11.8 %) | 149 (88.2 %) | 169 |